Fenofibrate enhances systemic antitumor efficacy of high- and low-dose radiotherapy plus PD-1 blockade through CD8+ T-cell metabolic reprogramming and LDRT tumor conditioning

Cancer Letters · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles